Cargando…

Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol

Anti-TNFα therapy has revolutionized the treatment of rheumatoid arthritis (RA) and other inflammatory diseases. These drugs are powerful and expensive. A new anti-TNFα agent, a nanomolecule comprising a humanized Fab’ antibody fragment against TNFα with a polyethylene glycol tail, is shortly to com...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Theresa, Moots, Robert
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673817/
https://www.ncbi.nlm.nih.gov/pubmed/17722505